Looks like no one added any tags here yet for you.
The FDAs orange book is defined as?
Approved drug products with therapeutic equivalence evaluations
Therapeutic equivalent is defined as
Having the same effect and safety
What is the criteria for the OB rating system?
FDA approved (NDA OR ANDA)
Pharmaceutical equivalent
Bioequivalent
What does B mean in the coding system?
equivalence suspect or not proven
could mean: not therapeutically equivalent, issues, potential for issues, insufficient date FDA
Does substituting a B-rated product violate federal law?
NO- however could violate state law
In the coding system the second letter means what?
Dosage form or product nature
AA: no bioequiv issues
AB: bioequiv issues resolved
AN: inhalation
AO: oils
AP: aqueous
AT: topical
Absent identifying code is deemed as
Adulterated and misbranded
Creation of generic biologics leads to
Competition
Decrease in price and Increase in efficacy and innovation
Why was the law change for biologics needed?
it previously only applied to products which are all small chemical compounds, and most of thes biomolecules are large in nature
BPCIA is similar to waxman hatch in that?
Congress is seeking a generic approval process to promote competition
Biosimilar definitions
Highly similar to the reference product
No clinically meaningful differences
NOT pharmaceutical equivalents
What is a key issue with biosimilars?
Interchangability
BPCIA is unlike waxman-hatch in that it requires some
Clinicals
For the BPCIA the sponsor must submit?
Structural and functional analysis
Animal and Human data
Title IV of the FDA Safety and Innovation act did what
provided for user fees to facilitate new product approval
Is the regulation of prescribing and dispensing state or federal?
States, they determine the conditions for prescribing and dispensing
FDA asserts it is misbranding for the pharmacist to dispense with out
PPI
Medguides
PPIs are dispensed
every time patient receives medication
Med guide drugs are
often part of REMS
and are required with every fill and refill
FDAAA accomplished what
Permit restrictions on distribution
Labeling changes - call doctor for medical advice about side effect
Expanded authority of FDA in the post marketing phase (REMS)
FDA may require REMS in the context of need to improve safety, an example of this may be
Patient communication plan
Professional communication plan
ETASU
What is the goal of REMS
Allow medication to stay on market by managing emergent risks
FDA requirements for addictive drugs
Training
Patient counseling
MedGuides
PPPA which was made by the CPSC left an exception for
OTCs, can label not for children
PPPA packaging examples include
Glass or threaded plastic one time use containers
For the PPPA how can a pharmacist dispense a drug without PPP
By having the patient sign a waiver once and keep on file
Failure to comply with CRP results in
Misbranding
CRP is different than tamper evident how?
Not designed to prevent access by children but to demonstrate potential tampering
Tamper evident/CRP can be both
adulterated and misbranded
Tummino v Hamburg ordered
All levonorgestrel-containing products made available without prescription based on citizen petition
What are the findings in the tummino case?
Levo is the safest OTC
Only acts pre fertilization
FDAs decision making process was inconsistent with past